GNRH1 and polycystic ovary syndrome: Comparing the effectiveness of pretreatment with or without GnRH-agonist for PCOS on clinical outcomes before FET, four RCTs [16, 18, 19, 29] and thirteen case–control studies [17, 23–28, 30–35] were analyzed.